{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:37:32Z","timestamp":1773293852256,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.chest.2022.10.012","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:09:55Z","timestamp":1675760995000},"page":"262-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Running on (Too\u00a0Many) Fumes? Gaseous Mediators in Septic Shock"],"prefix":"10.1016","volume":"163","author":[{"given":"Juan C.","family":"Diaz Soto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph G.S.","family":"Nabzdyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2022.10.012_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose IV hydroxocobalamin (Vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)","volume":"163","author":"Patel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.chest.2022.10.012_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.chest.2022.10.012_bib3","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s12325-020-01422-x","article-title":"Vasopressor-sparing action of methylene blue in severe sepsis and shock: a narrative review","volume":"37","author":"Puntillo","year":"2020","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.chest.2022.10.012_bib4","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3390\/ijms23073669","article-title":"Gases in sepsis: novel mediators and therapeutic targets","volume":"23","author":"Zhu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.chest.2022.10.012_bib5","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.3390\/molecules191221183","article-title":"Hydrogen sulfide and endothelium-dependent vasorelaxation","volume":"19","author":"Beltowski","year":"2014","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.chest.2022.10.012_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/SHK.0000000000000589","article-title":"Delayed Treatment with sodium hydrosulfide improves regional blood flow and alleviates cecal ligation and puncture (CLP)-induced septic shock","volume":"46","author":"Ahmad","year":"2016","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.chest.2022.10.012_bib7","doi-asserted-by":"crossref","first-page":"L960","DOI":"10.1152\/ajplung.00388.2006","article-title":"Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB","volume":"292","author":"Zhang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.chest.2022.10.012_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/SHK.0b013e31822bcfd0","article-title":"Total plasma sulfide as a marker of shock severity in nonsurgical adult patients","volume":"36","author":"Goslar","year":"2011","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.chest.2022.10.012_bib9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.freeradbiomed.2009.03.017","article-title":"Inhibition of nitric oxide synthase by cobalamins and cobinamides","volume":"46","author":"Weinberg","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.chest.2022.10.012_bib10","first-page":"257","article-title":"Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide","volume":"273","author":"Greenberg","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.chest.2022.10.012_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"issue":"4","key":"10.1016\/j.chest.2022.10.012_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000408","article-title":"Hydroxocobalamin in refractory septic shock: a retrospective case series","volume":"3","author":"Sacco","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.chest.2022.10.012_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcrc.2021.09.024","article-title":"Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shock","volume":"67","author":"Ritter","year":"2022","journal-title":"J\u00a0Crit Care"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222040028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222040028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T19:03:32Z","timestamp":1728846212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222040028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0012369222040028"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.012","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Running on (Too\u00a0Many) Fumes? Gaseous Mediators in Septic Shock","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.09.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}